These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 9862883

  • 1. Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics.
    Kellerman S, Alter MJ.
    Hepatology; 1999 Jan; 29(1):291-3. PubMed ID: 9862883
    [No Abstract] [Full Text] [Related]

  • 2. Management of hepatitis B and C in renal failure and renal transplant recipients.
    Amarapurkar D, Das HS.
    Trop Gastroenterol; 2002 Jan; 23(2):49-53. PubMed ID: 12632966
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Viral hepatitis in hemodialysis and renal transplantation patients].
    Pol S, Legendre C.
    Nephrologie; 1994 Jan; 15(3):191-5. PubMed ID: 7969710
    [Abstract] [Full Text] [Related]

  • 6. [Hepatitis C virus infection in patients with end stage renal disease].
    González-Michaca L.
    Rev Invest Clin; 2000 Jan; 52(5):546-56. PubMed ID: 11195183
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
    Moutinho RS, Perez RM, Pace FH, Ferreira AS, Cendoroglo M, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.
    Transplant Proc; 2005 Jun; 37(5):2080-2. PubMed ID: 15964344
    [Abstract] [Full Text] [Related]

  • 9. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H, Roushan MR, Al Hashemi GH, Dooki MR, Bai S.
    East Mediterr Health J; 2008 Jun; 14(4):798-803. PubMed ID: 19166162
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B and C in dialysis units in Iran: changing the epidemiology.
    Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S.
    Hemodial Int; 2008 Jul; 12(3):378-82. PubMed ID: 18638096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F, Bisegna S, Mangano S, Alongi G, Colucci P, Finazzi S, De Vecchi AF, Ponticelli C.
    G Ital Nefrol; 2002 Jul; 19(2):149-54. PubMed ID: 12195413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E, Senatore S, Ruggiero F, Papa R, Zaratti L.
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.
    Fabrizi F, Lampertico P, Lunghi G, Mangano S, Aucella F, Martin P.
    Aliment Pharmacol Ther; 2005 Mar 15; 21(6):623-32. PubMed ID: 15771749
    [Abstract] [Full Text] [Related]

  • 18. The management of viral hepatitis in CKD patients: an unresolved problem.
    Molino C, Fabbian F, Cozzolino M, Longhini C.
    Int J Artif Organs; 2008 Aug 15; 31(8):683-96. PubMed ID: 18825641
    [Abstract] [Full Text] [Related]

  • 19. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease.
    Pham T.
    CANNT J; 2001 Aug 15; 11(3):46. PubMed ID: 11785191
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.